Anthropic launched Claude for Life Sciences, a model aimed at research tasks and integrations with partners like 10x Genomics and Benchling to interrogate single‑cell datasets and streamline research workflows. The product targets scientists and drug developers seeking natural‑language interfaces for complex data. Separately, Genomics unveiled Mystra at ASHG — an AI‑enabled human genetics platform that packages harmonized GWAS and multiomic datasets to accelerate target discovery and clinical validation for drug R&D. The company promoted Mystra as a way to scale human‑genetics evidence across biopharma programs. Both releases highlight a near‑term industry pivot: companies are building domain‑specific LLMs and platforms that embed scientific datasets and analysis tools to reduce time from target insight to experimental validation. Expect adoption debates around data provenance, regulatory compliance and model interpretability.